De Novo Protein Sequencing
De novo protein sequencing is a technology that determines the amino acid sequence of a protein without relying on any existing DNA or protein database information. The principle is based on the regular fragmentation of peptide molecules after protease digestion in mass spectrometry. By identifying this specific fragmentation pattern, the amino acid information and post-translational modifications on the amino acids can be inferred from the mass differences between mass spectrometry peaks. Fragmentation of peptides in mass spectrometry produces different types of ions, with ions near the N-terminus being of types a, b, and c, and ions near the C-terminus being of types x, y, and z. The b-type ion is special because the bond break occurs between two amino acid residues. The mass difference between two adjacent b ions equals the mass of an amino acid residue. By exploiting the different mass characteristics of the R groups of different amino acids, the mass of the R group can be calculated from this mass difference, thereby determining the corresponding amino acid.
1. Methods of De Novo Protein Sequencing
1.Sample Preparation
(1) Protein Extraction and Purification: Extract target proteins from biological samples and purify them using centrifugation, chromatography, or electrophoresis to ensure protein purity of over 80%-90%, reducing the impact of impurities on subsequent de novo protein sequencing.
(2) Protease Digestion: Use trypsin, chymotrypsin, etc., to digest the sample and obtain peptide fragments suitable for de novo protein sequencing, employing multiple digestion strategies to cover the full sequence.
2.Mass Spectrometry Analysis
(1) Ionization: Use Electrospray Ionization (ESI) or Matrix-Assisted Laser Desorption/Ionization (MALDI) to ionize peptides for mass spectrometry analysis suitable for de novo protein sequencing.
(2) First Stage Mass Spectrometry Screening: Detect the mass-to-charge ratio (m/z) of peptide parent ions.
(3) Collision-Induced Dissociation: Introduce inert gas in the collision cell to induce peptide fragmentation and generate fragment ions.
(4) Second Stage Mass Spectrometry Analysis: Analyze fragment ion information to support the deduction of amino acid sequences in de novo protein sequencing.
3.Data Analysis
(1) Data Processing: Use software like PEAKS or Mascot to de-noise secondary mass spectrometry data, filter peaks, and optimize the quality of de novo protein sequencing data.
(2) Sequence Deduction: Deduce amino acid sequences based on mass spectrometry data and peptide fragmentation patterns, considering the impact of post-translational modifications.
(3) Sequence Validation: Validate results using Edman degradation or synthetic peptides to improve the accuracy of de novo protein sequencing.
2. De Novo Protein SequencingApplications and Limitations
1.Applications
De novo protein sequencing is commonly used for the discovery and identification of new proteins, with significant applications in microbiology, botany, and biopharmaceuticals. For example, when discovering new enzyme proteins in microbial strains, de novo protein sequencing can provide sequence information, laying the foundation for functional research.
2.Limitations
The de novo protein sequencing process is complex and requires very high-quality mass spectrometry data. Low-resolution or low-sensitivity mass spectrometry can lead to data interference, reducing sequencing accuracy. Additionally, complex fragmentation peaks of long peptides (exceeding 20-30 amino acids) also increase the difficulty and error in de novo protein sequencing.
Bioinformatics ServicesBiological ProductsCharacterization, High-Quality Multi-Omics Mass Spectrometry Detection Service Provider
Related Services:
How to order?
